speb/financial-data huggingface dataset:
ABUS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -85936000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -444000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -10664000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -5758000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -943000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Receivables: -424000.00
ABUS cash_flow (annual, 2023-12-31) — Change In Working Capital: -18233000.00
ABUS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -424000.00
ABUS cash_flow (annual, 2023-12-31) — Changes In Cash: -4516000.00
ABUS balance_sheet (annual, 2023-12-31) — Common Stock: 1349821000.00
ABUS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 106018000.00
ABUS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 29852000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 7048000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Assets: 132027000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 425000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 425000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 11791000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 11791000.00
ABUS balance_sheet (annual, 2023-12-31) — Current Liabilities: 22487000.00
ABUS cash_flow (annual, 2023-12-31) — Depreciation: 1404000.00
ABUS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1404000.00
ABUS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1404000.00
ABUS income_statement (annual, 2023-12-31) — Diluted Average Shares: 165960379.00
ABUS income_statement (annual, 2023-12-31) — Diluted EPS: -0.44
ABUS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -72849000.00
ABUS income_statement (annual, 2023-12-31) — EBIT: -72390000.00
ABUS income_statement (annual, 2023-12-31) — EBITDA: -70986000.00
ABUS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 25000.00
ABUS cash_flow (annual, 2023-12-31) — End Cash Position: 26285000.00
ABUS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 30647000.00
ABUS cash_flow (annual, 2023-12-31) — Free Cash Flow: -86944000.00
ABUS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -20000.00
ABUS income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 25000.00
ABUS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -48421000.00
ABUS income_statement (annual, 2023-12-31) — General And Administrative Expense: 22475000.00
ABUS balance_sheet (annual, 2023-12-31) — Gross PPE: 17990000.00
ABUS balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 6284000.00
ABUS income_statement (annual, 2023-12-31) — Interest Expense: 459000.00
ABUS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 459000.00
ABUS income_statement (annual, 2023-12-31) — Interest Income: 5688000.00
ABUS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 5688000.00
ABUS balance_sheet (annual, 2023-12-31) — Invested Capital: 106018000.00
ABUS cash_flow (annual, 2023-12-31) — Investing Cash Flow: 50773000.00
ABUS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 6284000.00
ABUS balance_sheet (annual, 2023-12-31) — Investments And Advances: 6284000.00
ABUS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 29852000.00
ABUS balance_sheet (annual, 2023-12-31) — Leases: 8590000.00
ABUS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1343000.00
ABUS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1343000.00
ABUS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 391000.00
ABUS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 29852000.00
ABUS income_statement (annual, 2023-12-31) — Net Income: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -72849000.00
ABUS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -72849000.00
ABUS income_statement (annual, 2023-12-31) — Net Interest Income: 5229000.00
ABUS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 51761000.00
ABUS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 5229000.00
ABUS balance_sheet (annual, 2023-12-31) — Net PPE: 6090000.00
ABUS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -988000.00
ABUS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 106018000.00
ABUS balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 0.00
ABUS balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 0.00
ABUS income_statement (annual, 2023-12-31) — Normalized EBITDA: -70942000.00
ABUS income_statement (annual, 2023-12-31) — Normalized Income: -72805000.00
ABUS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -85936000.00
ABUS cash_flow (annual, 2023-12-31) — Operating Gains Losses: -20000.00
ABUS income_statement (annual, 2023-12-31) — Operating Income: -78034000.00
ABUS income_statement (annual, 2023-12-31) — Operating Revenue: 18141000.00
ABUS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 169867414.00
ABUS balance_sheet (annual, 2023-12-31) — Other Current Assets: 4248000.00
ABUS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -48421000.00
ABUS income_statement (annual, 2023-12-31) — Other Gand A: 22475000.00
ABUS income_statement (annual, 2023-12-31) — Other Income Expense: -44000.00
ABUS cash_flow (annual, 2023-12-31) — Other Non Cash Items: -3343000.00
ABUS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 14553000.00
ABUS balance_sheet (annual, 2023-12-31) — Other Properties: 9009000.00
ABUS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 99718000.00
ABUS balance_sheet (annual, 2023-12-31) — Payables: 3223000.00
ABUS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 10271000.00
ABUS income_statement (annual, 2023-12-31) — Pretax Income: -72849000.00
ABUS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 795000.00
ABUS balance_sheet (annual, 2023-12-31) — Properties: 0.00
ABUS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -80509000.00
ABUS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1008000.00
ABUS balance_sheet (annual, 2023-12-31) — Receivables: 1776000.00
ABUS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1404000.00
ABUS income_statement (annual, 2023-12-31) — Research And Development: 73700000.00
ABUS income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 69000.00
ABUS balance_sheet (annual, 2023-12-31) — Retained Earnings: -1276652000.00
ABUS cash_flow (annual, 2023-12-31) — Sale Of Investment: 132270000.00
ABUS cash_flow (annual, 2023-12-31) — Sale Of PPE: 20000.00
ABUS income_statement (annual, 2023-12-31) — Selling General And Administration: 22475000.00
ABUS balance_sheet (annual, 2023-12-31) — Share Issued: 169867414.00
ABUS income_statement (annual, 2023-12-31) — Special Income Charges: -69000.00
ABUS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9301000.00
ABUS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 106018000.00
ABUS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 106018000.00
ABUS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (annual, 2023-12-31) — Tax Provision: 0.00
ABUS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ABUS balance_sheet (annual, 2023-12-31) — Total Assets: 144401000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Capitalization: 106018000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Debt: 1768000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 106018000.00
ABUS income_statement (annual, 2023-12-31) — Total Expenses: 96175000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 38383000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 12374000.00
ABUS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 15896000.00
ABUS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -78103000.00
ABUS income_statement (annual, 2023-12-31) — Total Unusual Items: -44000.00
ABUS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -44000.00
ABUS balance_sheet (annual, 2023-12-31) — Working Capital: 109540000.00
ABUS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 2964000.00
ABUS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 188997194.00
ABUS income_statement (quarterly, 2024-09-30) — Basic EPS: -0.10
ABUS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 188997194.00
ABUS income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.10
ABUS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 2964000.00
ABUS balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 2964000.00
ABUS balance_sheet (quarterly, 2024-09-30) — Other Properties: 17363000.00
ABUS cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
ABUS income_statement (annual, 2024-12-31) — +Operating Expense: 76145000.00
ABUS income_statement (annual, 2024-12-31) — +Total Revenue: 6171000.00
ABUS balance_sheet (annual, 2024-12-31) — Accounts Payable: 2316000.00
ABUS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 2409000.00
ABUS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -12996000.00
ABUS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 82048000.00
ABUS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -3135000.00
ABUS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 167000.00
ABUS income_statement (annual, 2024-12-31) — Basic Average Shares: 185608874.00
ABUS income_statement (annual, 2024-12-31) — Basic EPS: -0.38
ABUS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 26285000.00
ABUS cash_flow (annual, 2024-12-31) — Capital Expenditure: -182000.00
ABUS cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -86000.00
ABUS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1289000.00
ABUS balance_sheet (annual, 2024-12-31) — Capital Stock: 1410025000.00
ABUS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 36330000.00
ABUS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 122623000.00
ABUS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 51996000.00
ABUS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 22948000.00
ABUS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -64850000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -430000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1357000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2707000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 2298000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Receivables: -633000.00
ABUS cash_flow (annual, 2024-12-31) — Change In Working Capital: -2829000.00
ABUS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -633000.00
ABUS cash_flow (annual, 2024-12-31) — Changes In Cash: 10094000.00
ABUS balance_sheet (annual, 2024-12-31) — Common Stock: 1410025000.00
ABUS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 97366000.00
ABUS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 44123000.00
ABUS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -1000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 5248000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Assets: 127316000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 483000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 483000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 7571000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 7571000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 7571000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 7571000.00
ABUS balance_sheet (annual, 2024-12-31) — Current Liabilities: 15618000.00
ABUS cash_flow (annual, 2024-12-31) — Depreciation: 1380000.00
ABUS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1380000.00
ABUS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1380000.00
ABUS income_statement (annual, 2024-12-31) — Diluted Average Shares: 185608874.00
ABUS income_statement (annual, 2024-12-31) — Diluted EPS: -0.38
ABUS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -69920000.00
ABUS income_statement (annual, 2024-12-31) — EBIT: -69783000.00
ABUS income_statement (annual, 2024-12-31) — EBITDA: -68403000.00
ABUS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -49000.00
ABUS cash_flow (annual, 2024-12-31) — End Cash Position: 36330000.00
ABUS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 51996000.00
ABUS cash_flow (annual, 2024-12-31) — Free Cash Flow: -65032000.00
ABUS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ABUS cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ABUS income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
ABUS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -49000.00
ABUS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -48135000.00
ABUS income_statement (annual, 2024-12-31) — General And Administrative Expense: 22108000.00
ABUS balance_sheet (annual, 2024-12-31) — Gross PPE: 17353000.00
ABUS balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 0.00
ABUS balance_sheet (quarterly, 2024-12-31) — Held To Maturity Securities: 0.00
ABUS income_statement (annual, 2024-12-31) — Interest Expense: 137000.00
ABUS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 137000.00
ABUS income_statement (annual, 2024-12-31) — Interest Income: 6585000.00
ABUS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 6585000.00
ABUS balance_sheet (annual, 2024-12-31) — Invested Capital: 97366000.00
ABUS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 22948000.00
ABUS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
ABUS balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
ABUS balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
ABUS balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
ABUS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 44123000.00
ABUS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -1000.00
ABUS balance_sheet (annual, 2024-12-31) — Leases: 8590000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Leases: 8590000.00
ABUS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 806000.00
ABUS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 806000.00
ABUS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 477000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 477000.00
ABUS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 44123000.00
ABUS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1000.00
ABUS income_statement (annual, 2024-12-31) — Net Income: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -69920000.00
ABUS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -69920000.00
ABUS income_statement (annual, 2024-12-31) — Net Interest Income: 6448000.00
ABUS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 23130000.00
ABUS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 6448000.00
ABUS balance_sheet (annual, 2024-12-31) — Net PPE: 4357000.00
ABUS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -182000.00
ABUS cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -86000.00
ABUS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 97366000.00
ABUS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 2863000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 2863000.00
ABUS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 2863000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 2863000.00
ABUS income_statement (annual, 2024-12-31) — Normalized EBITDA: -62009000.00
ABUS income_statement (annual, 2024-12-31) — Normalized Income: -63526000.00
ABUS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -64850000.00
ABUS income_statement (annual, 2024-12-31) — Operating Income: -69974000.00
ABUS income_statement (annual, 2024-12-31) — Operating Revenue: 6171000.00
ABUS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 189963492.00
ABUS balance_sheet (annual, 2024-12-31) — Other Current Assets: 2284000.00
ABUS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -48135000.00
ABUS income_statement (annual, 2024-12-31) — Other Gand A: 22108000.00
ABUS income_statement (annual, 2024-12-31) — Other Income Expense: -6394000.00
ABUS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 501000.00
ABUS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 34000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 34000.00
ABUS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 15054000.00
ABUS balance_sheet (annual, 2024-12-31) — Other Properties: 8286000.00
ABUS balance_sheet (quarterly, 2024-12-31) — Other Properties: 8286000.00
ABUS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 86293000.00
ABUS balance_sheet (annual, 2024-12-31) — Payables: 2316000.00
ABUS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 7564000.00
ABUS income_statement (annual, 2024-12-31) — Pretax Income: -69920000.00
ABUS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 7873000.00
ABUS balance_sheet (annual, 2024-12-31) — Properties: 0.00
ABUS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ABUS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -141509000.00
ABUS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -182000.00
ABUS cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -86000.00
ABUS balance_sheet (annual, 2024-12-31) — Receivables: 2409000.00
ABUS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1380000.00
ABUS income_statement (annual, 2024-12-31) — Research And Development: 54037000.00
ABUS income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 6345000.00
ABUS balance_sheet (annual, 2024-12-31) — Retained Earnings: -1346572000.00
ABUS cash_flow (annual, 2024-12-31) — Sale Of Investment: 164639000.00
ABUS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
ABUS cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
ABUS income_statement (annual, 2024-12-31) — Selling General And Administration: 22108000.00
ABUS balance_sheet (annual, 2024-12-31) — Share Issued: 189963492.00
ABUS income_statement (annual, 2024-12-31) — Special Income Charges: -6345000.00
ABUS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8986000.00
ABUS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 97366000.00
ABUS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 97366000.00
ABUS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (annual, 2024-12-31) — Tax Provision: 0.00
ABUS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
ABUS balance_sheet (annual, 2024-12-31) — Total Assets: 131707000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Capitalization: 97366000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Debt: 1289000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 97366000.00
ABUS income_statement (annual, 2024-12-31) — Total Expenses: 76145000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 34341000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4391000.00
ABUS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 18723000.00
ABUS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -76319000.00
ABUS income_statement (annual, 2024-12-31) — Total Unusual Items: -6394000.00
ABUS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -6394000.00
ABUS balance_sheet (annual, 2024-12-31) — Working Capital: 111698000.00
ABUS income_statement (quarterly, 2025-03-31) — +Operating Expense: 14791000.00
ABUS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1764000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2240000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1182000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -13326000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 82089000.00
ABUS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -718000.00
ABUS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 2811000.00
ABUS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 190707085.00
ABUS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
ABUS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 36330000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1189000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1416332000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 37076000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 112707000.00
ABUS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2784000.00
ABUS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 11349000.00
ABUS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -13391000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 4545000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -104000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -812000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Payable: 4545000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 4545000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 413000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1227000.00
ABUS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 5269000.00
ABUS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1227000.00
ABUS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 742000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1416332000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 79157000.00
ABUS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 3904000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Assets: 116808000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 563000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 563000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 6759000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 6759000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19431000.00
ABUS cash_flow (quarterly, 2025-03-31) — Depreciation: 330000.00
ABUS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 330000.00
ABUS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 330000.00
ABUS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 190707085.00
ABUS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
ABUS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — EBIT: -24498000.00
ABUS income_statement (quarterly, 2025-03-31) — EBITDA: -24168000.00
ABUS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 4000.00
ABUS cash_flow (quarterly, 2025-03-31) — End Cash Position: 37076000.00
ABUS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2784000.00
ABUS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -13391000.00
ABUS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 4000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -48166000.00
ABUS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5832000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 13494000.00
ABUS income_statement (quarterly, 2025-03-31) — Interest Expense: 28000.00
ABUS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 28000.00
ABUS income_statement (quarterly, 2025-03-31) — Interest Income: 1197000.00
ABUS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1197000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 79157000.00
ABUS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 11349000.00
ABUS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
ABUS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 626000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 626000.00
ABUS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -24526000.00
ABUS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -24526000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Interest Income: 1169000.00
ABUS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 11349000.00
ABUS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 1169000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Net PPE: 168000.00
ABUS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
ABUS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 79157000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2863000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 2863000.00
ABUS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -11500000.00
ABUS income_statement (quarterly, 2025-03-31) — Normalized Income: -11858000.00
ABUS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -13391000.00
ABUS income_statement (quarterly, 2025-03-31) — Operating Income: -13027000.00
ABUS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1764000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 191481474.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2919000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 5965000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -48166000.00
ABUS income_statement (quarterly, 2025-03-31) — Other Gand A: 5832000.00
ABUS income_statement (quarterly, 2025-03-31) — Other Income Expense: -12668000.00
ABUS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -121000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 34000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 14933000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Properties: 13494000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 75631000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Payables: 2240000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6144000.00
ABUS income_statement (quarterly, 2025-03-31) — Pretax Income: -24526000.00
ABUS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 2784000.00
ABUS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -34716000.00
ABUS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
ABUS balance_sheet (quarterly, 2025-03-31) — Receivables: 1182000.00
ABUS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 330000.00
ABUS income_statement (quarterly, 2025-03-31) — Research And Development: 8959000.00
ABUS income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 12672000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1371098000.00
ABUS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 46065000.00
ABUS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5832000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Share Issued: 191481474.00
ABUS income_statement (quarterly, 2025-03-31) — Special Income Charges: -12672000.00
ABUS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3564000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 79157000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 79157000.00
ABUS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ABUS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Assets: 117010000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 79157000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1189000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 79157000.00
ABUS income_statement (quarterly, 2025-03-31) — Total Expenses: 14791000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 37853000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 202000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 18422000.00
ABUS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -25699000.00
ABUS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -12668000.00
ABUS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12668000.00
ABUS balance_sheet (quarterly, 2025-03-31) — Working Capital: 97377000.00
ABUS income_statement (quarterly, 2025-06-30) — +Operating Expense: 8826000.00
ABUS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1953255.73
ABUS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1321000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1025000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -13315000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 82628000.00
ABUS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -668000.00
ABUS cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
ABUS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 191551282.00
ABUS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
ABUS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 37076000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1089000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1417110000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 37412000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 98088000.00
ABUS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 453000.00
ABUS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 15611000.00
ABUS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -15749000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -121000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -9622000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -7601000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -1053000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Receivables: 157000.00
ABUS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -18240000.00
ABUS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 157000.00
ABUS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 315000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Common Stock: 1417110000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 82976000.00
ABUS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 2419000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Assets: 103119000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 514000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 514000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 5022000.00
ABUS cash_flow (quarterly, 2025-06-30) — Depreciation: 11000.00
ABUS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 11000.00
ABUS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 11000.00
ABUS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 192399733.00
ABUS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
ABUS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — EBIT: 2551000.00
ABUS income_statement (quarterly, 2025-06-30) — EBITDA: 2562000.00
ABUS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 21000.00
ABUS cash_flow (quarterly, 2025-06-30) — End Cash Position: 37412000.00
ABUS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 453000.00
ABUS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -15749000.00
ABUS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 21000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -48187000.00
ABUS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3328000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 13463000.00
ABUS income_statement (quarterly, 2025-06-30) — Interest Expense: 28000.00
ABUS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 28000.00
ABUS income_statement (quarterly, 2025-06-30) — Interest Income: 1042000.00
ABUS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 1042000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 82976000.00
ABUS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 15611000.00
ABUS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 575000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 575000.00
ABUS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2523000.00
ABUS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2523000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Interest Income: 1014000.00
ABUS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 15602000.00
ABUS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 1014000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Net PPE: 148000.00
ABUS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 9000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 82976000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 0.00
ABUS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2966000.00
ABUS income_statement (quarterly, 2025-06-30) — Normalized Income: 2842160.00
ABUS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -15749000.00
ABUS income_statement (quarterly, 2025-06-30) — Operating Income: 1913000.00
ABUS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1953255.73
ABUS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 191641511.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 4006000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 768000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -48187000.00
ABUS income_statement (quarterly, 2025-06-30) — Other Gand A: 3328000.00
ABUS income_statement (quarterly, 2025-06-30) — Other Income Expense: -404000.00
ABUS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -239000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 14694000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Properties: 13463000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 60676000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Payables: 1321000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3740000.00
ABUS income_statement (quarterly, 2025-06-30) — Pretax Income: 2523000.00
ABUS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 453000.00
ABUS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -28498000.00
ABUS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
ABUS balance_sheet (quarterly, 2025-06-30) — Receivables: 1025000.00
ABUS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 11000.00
ABUS income_statement (quarterly, 2025-06-30) — Research And Development: 5498000.00
ABUS income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 425000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1368575000.00
ABUS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 44100000.00
ABUS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3328000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Share Issued: 191641511.00
ABUS income_statement (quarterly, 2025-06-30) — Special Income Charges: -425000.00
ABUS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 864000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 82976000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 82976000.00
ABUS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -84840.00
ABUS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ABUS balance_sheet (quarterly, 2025-06-30) — Total Assets: 103267000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 82976000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Debt: 1089000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 82976000.00
ABUS income_statement (quarterly, 2025-06-30) — Total Expenses: 8826000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 20291000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 148000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 15269000.00
ABUS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1488000.00
ABUS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -404000.00
ABUS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -404000.00
ABUS balance_sheet (quarterly, 2025-06-30) — Working Capital: 98097000.00
ABUS income_statement (quarterly, 2025-09-30) — +Operating Expense: 8822000.00
ABUS income_statement (quarterly, 2025-09-30) — +Total Revenue: 529000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1011000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 905000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -13347000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 83285000.00
ABUS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -541000.00
ABUS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
ABUS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 191778950.00
ABUS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.04
ABUS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 37412000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 922000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1418560000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 22408000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 93702000.00
ABUS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 844000.00
ABUS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -10019000.00
ABUS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5817000.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -155000.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 0.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 145000.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1040000.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 120000.00
ABUS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1150000.00
ABUS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 120000.00
ABUS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -14992000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Common Stock: 1418560000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 77399000.00
ABUS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2879000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Assets: 97442000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 531000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 531000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 5184000.00
ABUS cash_flow (quarterly, 2025-09-30) — Depreciation: 11000.00
ABUS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 11000.00
ABUS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 11000.00
ABUS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 191778950.00
ABUS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.04
ABUS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — EBIT: -7719000.00
ABUS income_statement (quarterly, 2025-09-30) — EBITDA: -7708000.00
ABUS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -12000.00
ABUS cash_flow (quarterly, 2025-09-30) — End Cash Position: 22408000.00
ABUS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 844000.00
ABUS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5817000.00
ABUS income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -12000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -48129000.00
ABUS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3044000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 13484000.00
ABUS income_statement (quarterly, 2025-09-30) — Interest Expense: 23000.00
ABUS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 23000.00
ABUS income_statement (quarterly, 2025-09-30) — Interest Income: 952000.00
ABUS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 952000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 77399000.00
ABUS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -10019000.00
ABUS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 391000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 391000.00
ABUS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7742000.00
ABUS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7742000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Interest Income: 929000.00
ABUS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -10019000.00
ABUS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 929000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Net PPE: 137000.00
ABUS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 77399000.00
ABUS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 0.00
ABUS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 0.00